10 m.c./cm3 on a gamma-installation in a dose of 140-150 Gr with following thermostating and extraction of radiotoxin with 70% acidified with 0.05% hydrochloric acid to pH 5.5 ethanol, following evaporation of the exractant to the initial volume, after that, obtaining protein-cadmium radioantigen first by preliminary dechlorination of cadmium chloride, obtaining cadmium hydroxide, addition into the obtained 2.7% solution of the antigen of 0.77% solution of cadmium hydroxide in a ratio of 1:1 with following thermostating at a temperature of 37°C for 30 minutes, evaporation and dissolution of the residue to 12.8% concentration, further obtaining protein-cadmium radioantigen by an addition of 1.2% solution of a mixture of three anatoxins of E.coli and 12.8% solution of cadmium radioantigen in a ratio of 1:9, conjugation of components at room temperature for 8-10 hours, standardisation by a dry substance to 10% concentration and pouring into vials, and storage at a temperature of 4-6°C. The group of inventions also relates to a method of treating radiation, chemical and/or bacteriological damage to an organism by introduction of 10% solution of complex protein-cadmium radioantigen.;EFFECT: application of the group of inventions is effective in treatment of radiation, chemical and/or biological damage.;4 cl, 6 ex"/> METHOD FOR THE TREATMENT OF RADIATION AND CHEMICAL SCIENCES OF THE BODY AND METHOD FOR THE TREATMENT OF PRODUCING globulin radiation-chemical-biological attack ORGANISM
首页> 外国专利> METHOD FOR THE TREATMENT OF RADIATION AND CHEMICAL SCIENCES OF THE BODY AND METHOD FOR THE TREATMENT OF PRODUCING globulin radiation-chemical-biological attack ORGANISM

METHOD FOR THE TREATMENT OF RADIATION AND CHEMICAL SCIENCES OF THE BODY AND METHOD FOR THE TREATMENT OF PRODUCING globulin radiation-chemical-biological attack ORGANISM

机译:辐射化学的方法和身体的化学疗法以及产生球蛋白放射化学生物攻击生物的方法

摘要

FIELD: medicine.;SUBSTANCE: group of inventions relates to veterinary and medicine, in particular to obtaining and application of biopreparations for immunotherapy of ecopathologies. The group of inventions includes obtaining a protein antigen from a mixture of anatoxins from three enteropathogenic virulent strains of a pathogen of escherichiosis of calves E.coli No. 378, 379, 380 by their growing on Hottinger medium with further addition of 0.4-0.5% formalin, following thermostating for 10-12 days and cooling the mixture of anatoxins with a sterile solution of aluminium hydroxide, after that obtaining radioantigen from E.coli "PL-6" by growing cultures on a meat infusion agar with further washing away a biomass by a physiological solution and irradiation of the obtained suspension with a concentration of 1.2·1010 m.c./cm3 on a gamma-installation in a dose of 140-150 Gr with following thermostating and extraction of radiotoxin with 70% acidified with 0.05% hydrochloric acid to pH 5.5 ethanol, following evaporation of the exractant to the initial volume, after that, obtaining protein-cadmium radioantigen first by preliminary dechlorination of cadmium chloride, obtaining cadmium hydroxide, addition into the obtained 2.7% solution of the antigen of 0.77% solution of cadmium hydroxide in a ratio of 1:1 with following thermostating at a temperature of 37°C for 30 minutes, evaporation and dissolution of the residue to 12.8% concentration, further obtaining protein-cadmium radioantigen by an addition of 1.2% solution of a mixture of three anatoxins of E.coli and 12.8% solution of cadmium radioantigen in a ratio of 1:9, conjugation of components at room temperature for 8-10 hours, standardisation by a dry substance to 10% concentration and pouring into vials, and storage at a temperature of 4-6°C. The group of inventions also relates to a method of treating radiation, chemical and/or bacteriological damage to an organism by introduction of 10% solution of complex protein-cadmium radioantigen.;EFFECT: application of the group of inventions is effective in treatment of radiation, chemical and/or biological damage.;4 cl, 6 ex
机译:领域:一组发明涉及兽医和医学,尤其涉及用于生态病理学免疫疗法的生物制剂的获得和应用。本发明的组包括通过在Hottinger培养基上生长并进一步添加0.4-0.5%从三株小牛大肠杆菌378、379、380号大肠杆菌病原体的致病性强毒株的抗毒素混合物中获得蛋白抗原。福尔马林,恒温10-12天并用无菌氢氧化铝溶液冷却抗毒素混合物,然后通过在肉浸琼脂上培养并进一步洗去生物质从大肠杆菌“ PL-6”中获得放射抗原通过生理溶液并以140-150 Gr的剂量将所得浓度为1.2·10 10 mc / cm 3 的悬浮液辐照在伽马装置上恒温并用70%的放射性毒素提取并用0.05%盐酸酸化至pH 5.5乙醇,然后将萃取液蒸发至初始体积,然后,首先通过对c进行初步脱氯获得蛋白质-镉放射性抗原氯化镉,得到氢氧化镉,然后在37℃的温度下恒温30分钟后,以1:1的比例将0.77%的氢氧化镉溶液的抗原加入到所获得的2.7%的抗原溶液中。残留物达到12.8%的浓度,通过以1.2:3的比例添加大肠杆菌的三种抗毒素混合物和12.8%的镉放射抗原溶液的混合物,从而进一步获得蛋白质-镉放射性抗原,并在室温下偶联各组分干燥8-10小时,用干物质标准化至10%浓度,倒入小瓶中,并在4-6°C的温度下存储。本发明组还涉及通过引入10%的复杂蛋白质-镉放射抗原溶液来治疗对生物体的放射线,化学和/或细菌学损害的方法。效果:该组发明的应用在放射线治疗中是有效的,化学和/或生物损坏。; 4 cl,6 ex

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号